FARON PHARMACEUTICALS OY (FARN) — research page
UK · uk-cm-kg/AIM/FARN · as of 2026-11-06
Identity and listing
The issuer is FARON PHARMACEUTICALS OY, listed on AIM under ticker FARN, ISIN FI4000153309, LEI 7437009H31TO1DC0EB42. Its security type is Corporate, its segment is ASQ1, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is Finland (FI). The record holds its listing status as listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | FARON PHARMACEUTICALS OY | source · 2026-11-06 |
| exchange | AIM | source · 2026-11-06 |
| ticker | FARN | source · 2026-11-06 |
| ISIN | FI4000153309 | source · 2026-11-06 |
| LEI | 7437009H31TO1DC0EB42 | source · 2026-11-06 |
| security type | Corporate | source · 2026-11-06 |
| segment | ASQ1 | source · 2026-11-06 |
| sector | Pharmaceuticals and Biotechnology [201030] | source · 2026-11-06 |
| jurisdiction | Finland (FI) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 77 filings in the twelve months to 2026-11-06, across 60 filing days. The filings are 67 regulatory announcements, 7 director dealings, 2 financial statements and 1 halt and resume. The median gap between filing days is 3 days. The latest filing is a regulatory announcement dated 2026-11-04, 2 days before the record date. On AIM the median filings count is 33.5, the median cadence gap is 7.0 days and the median latency is 4 days across 594 issuers. In the sector the median filings count is 42, the median cadence gap is 6.0 days and the median latency is 4.0 days across 51 issuers.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 77 | 3 | 2 |
| exchange median: AIM (594 issuers) | 33.5 | 7 | 4 |
| sector median: Pharmaceuticals and Biotechnology [201030] (51 issuers) | 42 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-04 | regulatory_announcement | Faron Announces Five ASH 2026 Abstracts Spann... | |
| 2026-10-06 | regulatory_announcement | Composition of Faron Pharmaceutical’s Shareho... | |
| 2026-09-07 | regulatory_announcement | FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMP... | |
| 2026-09-04 | regulatory_announcement | FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMP... | |
| 2026-08-26 | regulatory_announcement | Faron Pharmaceuticals Ltd: Half-year financia... |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record. The auditor's location is not on the record. Auditor changes are not on the record, as the market's register has no lifecycle type map yet.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as the market's register has no lifecycle type map yet. The halt flag reads listed, not halted.
Orderability
For elective professional client the outcome is signal ACM-200, determinable. For eligible counterparty the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04.
| client category | outcome |
|---|---|
| elective professional client | ACM-200 |
| eligible counterparty | ACM-200 |
rule acm-68000/uk/product-governance-fca-prod-sourcebook/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 9 research houses: Kempen, Carnegie, Redeye, Inderes, H.C.WAINWRIGHT&CO, Peel Hunt, Kepler Chevreaux, Panmure Gordon and Stifel Research.
| research house | analyst | source · read date |
|---|---|---|
| Kempen | Chiara Montironi | issuer page · 2026-11-12 |
| Carnegie | Klas Palin | issuer page · 2026-11-12 |
| Redeye | Kevin Sule | issuer page · 2026-11-12 |
| Inderes | Antti Siltanen | issuer page · 2026-11-12 |
| H.C.WAINWRIGHT&CO | Patrick R, Trucchio | issuer page · 2026-11-12 |
| Peel Hunt | Miles Dixon | issuer page · 2026-11-12 |
| Kepler Chevreaux | Jon Berggren | issuer page · 2026-11-12 |
| Panmure Gordon | Julie Simmonds | issuer page · 2026-11-12 |
| Stifel Research | issuer page · 2026-11-12 |
Open research
No openly published research notes were found for the issuer.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
No issuer years are sealed. The market's vintage is not sealed and no earliest sealed date is held. The live record began 2026-09-11. The years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.
Sources
9 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)
- 10.2
- https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/FARN (identity.isin)
- 10.3
- https://api.gleif.org/api/v1/lei-records/7437009H31TO1DC0EB42 (identity.jurisdiction)
- 10.4
- https://www.londonstockexchange.com/stock/FARN/faron-pharmaceuticals-oy/company-page (identity.sector)
- 10.5
- https://mcp.uk-cm-kg.ai/events/AIM/FARN (the disclosure lines)
- 10.6
- https://marketsecurities.fca.org.uk/officiallist (the halt flag)
- 10.7
- https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://faron.com/investors/faron-as-an-investment/forecasts-and-analysis-analysts/ (coverage)
- 10.9
- https://mcp.uk-cm-kg.ai/record/AIM/FARN (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"FI4000153309"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:75558cf08d68f141.